BofA Securities Downgrades Tyra Biosciences (TYRA) to Neutral

BofA Securities analyst Geoff Meacham downgraded Tyra Biosciences (NASDAQ: TYRA) from Buy to Neutral with a price target of $15.00 (from $25.00).

For an analyst ratings summary and ratings history on Tyra Biosciences click here. For more ratings news on Tyra Biosciences click here.

Shares of Tyra Biosciences closed at $14.78 yesterday.

You May Also Be Interested In

• Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
• Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation
• Target (TGT) PT Raised to $170 at DA Davidson Ahead of Q2 Earnings